EWTX
NASDAQ · Pharmaceuticals
Edgewise Therapeutics Inc
$45.04
+6.17 (+15.87%)
Performance
1D
+0.00%
1W
+18.18%
1M
+14.81%
3M
+1.03%
6M
+30.32%
1Y
+162.47%
YTD
+89.64%
Open$39.71
Previous Close$38.87
Day High$45.76
Day Low$38.05
52W High$48.51
52W Low$16.70
Volume—
Avg Volume1.59M
Market Cap4.89B
P/E Ratio—
EPS$-1.85
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$40.85
Above
SMA 200
$36.55
Above
RSI (14)
73.9
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+56.4% upside
Current
$45.04
$45.04
Target
$70.44
$70.44
$45.77
$70.44 avg
$86.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 407.17M | 429.50M | 324.39M |
| Net Income | 72.15M | 91.13M | 54.38M |
| Profit Margin | 17.7% | 21.2% | 16.8% |
| EBITDA | 147.48M | 172.82M | 113.17M |
| Free Cash Flow | 69.60M | 65.40M | 42.96M |
| Rev Growth | +16.1% | +0.2% | +22.1% |
| Debt/Equity | 0.29 | 0.25 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |